Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001063207 | SCV001228043 | pathogenic | not provided | 2023-04-27 | criteria provided, single submitter | clinical testing | Experimental studies have shown that this missense change affects ALPL function (PMID: 11760847, 19500388). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALPL protein function. ClinVar contains an entry for this variant (Variation ID: 550626). This variant is also known as Arg374His. This missense change has been observed in individuals with autosomal dominant hypophosphatasia (PMID: 11760847, 19500388, 25731960; Invitae). This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 391 of the ALPL protein (p.Arg391His). |
| Seattle Children's Hospital Molecular Genetics Laboratory, |
RCV001532998 | SCV001745391 | pathogenic | Childhood hypophosphatasia | 2021-07-06 | criteria provided, single submitter | clinical testing | A heterozygous pathogenic variant was identified in ALPL (NM_000478.4:c.1172G>A, p.Arg391His, rs1442918125). The result is consistent with a diagnosis of ALPL-related hypophosphatasia. No additional clinically significant variants in ALPL were observed. The c.1172G>A variant is located in exon 10 of the ALPL gene. This variant substitutes the arginine with histidine at amino acid position 391 of the protein. The p.Arg391His variant has previously been reported in two unrelated individuals with hypophosphatasia (PMID: 11760847, 19500388). One individual had odontohypophosphatasia (PMID: 11760847), whereas the other individual had childhood-onset hypophosphatasia at 18 months of age characterized by rib fractures (PMID: 19500388). A second pathogenic ALPL variant was not identified in either reported case. This is a conserved nucleotide across species and several in silico tools predict this substitution would be damaging to protein function. Experimental studies have demonstrated that the p.Arg391His change causes a near complete loss of ALPL enzymatic activity (PMID: 11760847). Further supporting pathogenicity of this variant, a different missense change at the same residue (p.Arg391Cys) has been reported in multiple individuals with hypophosphatasia (PMID: 19500388, 10332035). In the case of childhood-onset hypophosphatasia, the p.Arg391His variant was inherited from a parent, but no clinical information was provided for this parent (PMID: 19500388). The p.Arg391His variant has also been observed in 3 of 282,880 alleles in a large population study (GnomAD v2.1). While individuals with severe pediatric disease have been removed from this dataset, it remains possible that individuals with mild or adult-onset forms of hypophosphatasia are included in this cohort. With the currently available information, ALPL p.Arg391His is considered a pathogenic variant, albeit with variable expressivity and possibly reduced penetrance, as has been observed for other pathogenic ALPL variants (NBK1150). Hypophosphatasia may be inherited in an autosomal recessive or autosomal dominant manner. |
| Gene |
RCV001063207 | SCV003930137 | pathogenic | not provided | 2023-07-14 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate the R391H variant has reduced activity compared to wildtype, which is consistent with loss of function (Fauvert et al., 2009; Del Angel et al., 2020); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32160374, 11760847, 34662886, 19500388, 29236161, 37422472) |
| Baylor Genetics | RCV004568492 | SCV005057959 | pathogenic | Adult hypophosphatasia | 2024-01-27 | criteria provided, single submitter | clinical testing | |
| Mayo Clinic Laboratories, |
RCV001063207 | SCV005414349 | pathogenic | not provided | 2024-03-22 | criteria provided, single submitter | clinical testing | PP3, PP4, PM5, PS3, PS4_moderate |
| Counsyl | RCV000665417 | SCV000789536 | uncertain significance | Infantile hypophosphatasia | 2017-02-08 | flagged submission | clinical testing |